SCHEMBL35277

SCHEMBL35277

c1ncc2c(n1)CCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29438246 1.00
SCHEMBL556889 0.95 SIGMAR1 (0.43)
SCHEMBL29460883 0.95 SIGMAR1 (0.43)
SCHEMBL2940094 0.93 SIGMAR1 (0.41)
SCHEMBL3988316 0.93 SIGMAR1 (0.41)
SCHEMBL3987657 0.93 SIGMAR1 (0.41)
SCHEMBL19450091 0.93 SIGMAR1 (0.41)
SCHEMBL2946238 0.93 SIGMAR1 (0.41)
SCHEMBL19450166 0.93 SIGMAR1 (0.41)
SCHEMBL9536810 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434247-B1 Substituted furanopyrimidine compounds as PDE1 inhibitors DART NEUROSCIENCE LLC (US) 2022-09-06 US claimed
EP-3717488-B1 SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS DART NEUROSCIENCE LLC (US) 2021-09-29 EP claimed
US-11117887-B2 Aryl substituted pyrimidines for use in influenza virus infection Janssen Sciences Ireland Unlimited Company (IE) 2021-09-14 US claimed
EP-3717488-A1 SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS Dart NeuroScience, LLC (US) 2020-10-07 EP claimed
CN-111655695-A Substituted furopyrimidines as PDE1 inhibitors 达特神经科学有限公司 2020-09-11 CN claimed
WO-2019104285-A1 SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS DART NEUROSCIENCE, LLC (US) 2019-05-31 WO claimed
US-20120035190-A1 E-type Phenyl Acrylic Ester Compounds Containing Substituted Anilino Pyrimidine Group and Uses Thereof SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) 2012-02-09 US claimed
US-20110201628-A1 HETEROCYCLIC JAK KINASE INHIBITORS ASTRAZENECA AB (SE) 2011-08-18 US claimed
CN-1845907-B Guanidine derivatives ACTELION PHARMACEUTICALS LTD 2010-07-28 CN claimed
US-7544691-B2 Guanidine derivatives ACTELION PHARMACEUTICALS, LTD. (CH) 2009-06-09 US claimed
EP-1663993-B1 GUANIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2008-03-12 EP claimed
US-20070123510-A1 Guanidine derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2007-05-31 US claimed
CN-1845907-A Guanidine derivatives ACTELION PHARMACEUTICALS LTD (CH) 2006-10-11 CN claimed
EP-1299397-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESS FOR PREPARING THE SAME LG Life Sciences Ltd. (KR) 2003-04-09 EP claimed
WO-2002004464-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESS FOR PREPARING THE SAME LG LIFE SCIENCES LTD (KR) 2002-01-17 WO claimed
EP-0530579-B1 Condensed pyrimidine derivatives antitumor agents EISAI CO LTD (JP) 1998-11-11 EP claimed
US-5688800-A ANTITUMOR AGENTS EISAI CO., LTD. (JP) 1997-11-18 US claimed
EP-0530579-A1 Condensed pyrimidine derivatives antitumor agents Eisai Co., Ltd. (JP) 1993-03-10 EP claimed
US-12637440-B2 Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof LG CHEM, LTD. (KR) 2026-05-26 US disclosed
EP-0057440-B1 AMINOPYRIMIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND FUNGICIDAL, INSECTICIDAL AND ACARICIDAL COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1985-05-22 EP disclosed